Torres P Ureña
Service de Néphrologie et Dialyse, Clinique de l'Orangerie, Aubervilliers, France.
Kidney Int. 2006 Jul;70(2):240-3. doi: 10.1038/sj.ki.5001658.
Serum parathyroid hormone (PTH) is a recognized marker of bone remodeling in patients with renal osteodystrophy. However, identification of N-terminal truncated PTH fragments and a new form of PTH that interfere with second-generation PTH assays may be responsible for the great variability of PTH values and the difficulties of implementing the recommendations of the National Kidney Foundation/Kidney Disease Outcomes Quality Initiative.
